Li, S., Zhu, C., Zhou, X., Chen, L., Bo, X., Shen, Y., . . . Yue, W. (2022). Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley.
Style de citation ChicagoLi, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.
Style de citation MLALi, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.
Attention : ces citations peuvent ne pas être correctes à 100%.